Thirty-nine women with nonmetastatic
gestational trophoblastic disease as determined by conventional staging studies were prospectively evaluated with computed axial tomography (CAT) of the lungs. Sixteen patients (41%) had pulmonary
micrometastases detected by CAT, which were not detected by routine chest x-ray. Eight patients (20.5%) had indeterminate scans, and only 15 patients (38%) had negative scans. Eight of 16 patients (50%) with pulmonary
micrometastases failed initial
therapy with
methotrexate-
folinic acid rescue while one of eight (12.5%) patients in the indeterminate group and one of 15 (6.7%) patients in the true nonmetastatic group failed initial
therapy (P less than .006). All patients who failed
methotrexate-
folinic acid rescue ultimately achieved prolonged remission with
actinomycin D. Time to remission was significantly decreased in patients without evidence of pulmonary
micrometastases (P = .03), but the total number of courses of
chemotherapy was not significantly different (P = .06). No life-threatening toxicity occurred. Pulmonary
micrometastases detected by CAT but not chest x-ray are predictive of an increased risk of
methotrexate-
folinic acid therapy failure. Computed axial tomography of the lungs identifies a group of patients at high risk for failure of
methotrexate-
folinic acid rescue, and, therefore, may be indicated for routine staging of patients with otherwise nonmetastatic
gestational trophoblastic disease.